Cantor Fitzgerald Weighs in on Agile Therapeutics, Inc.'s FY2016 Earnings (AGRX)

Share
Cantor Fitzgerald Weighs in on Agile Therapeutics, Inc.'s FY2016 Earnings (AGRX)

Equities researchers at Cantor Fitzgerald issued their FY2016 earnings estimates for Agile Therapeutics in a report released on Tuesday. Cantor Fitzgerald analyst E. Piros now expects that the firm will earn ($0.59) per share for the year, up from their previous forecast of ($0.78). Cantor Fitzgerald has a "Buy" rating and a $37.00 price target on the stock. Cantor Fitzgerald also issued estimates for Agile Therapeutics' FY2017 earnings at ($1.42) EPS. Raymond James Financial, Inc. initiated coverage on Flexion Therapeutics in a research report on Thursday, December 22nd. Finally, BCS dropped their target price on Flexion Therapeutics from $0.65 to $0.02 in a research report on Tuesday, November 8th. One analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. If you are viewing this story on another publication, it was illegally copied and reposted in violation of USA and worldwide copyright legislation. The original version of this article can be viewed at https://www.com-unik.info/2017/01/13/cantor-fitzgerald-weighs-in-on-agile-therapeutics-inc-s-fy2016-earnings-agrx.html.

Axsome Therapeutics (NASDAQ:AXSM) opened at 6.45 on Tuesday. The company's 50-day moving average is $6.63 and its 200-day moving average is $7.27. The company's market capitalization is $528.24 million. Agile Therapeutics has a 52-week low of $1.82 and a 52-week high of $8.65.

Flexion Therapeutics (NASDAQ:FLXN) last announced its earnings results on Monday, November 7th. The biopharmaceutical company reported ($0.08) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.19) by $0.11.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. RTW Investments LLC purchased a new position in shares of Abeona Therapeutics during the third quarter valued at about $116,000. ProShare Advisors LLC now owns 18,320 shares of the specialty pharmaceutical company's stock valued at $274,000 after buying an additional 783 shares in the last quarter. American International Group Inc. now owns 10,656 shares of the specialty pharmaceutical company's stock valued at $159,000 after buying an additional 810 shares in the last quarter. 461,786 shares of the company's stock traded hands. Rhumbline Advisers increased its position in shares of Flexion Therapeutics by 18.3% in the third quarter. Finally, Bank of New York Mellon Corp bought a new stake in Axsome Therapeutics during the second quarter valued at $161,000. Teachers Advisors Inc. now owns 19,401 shares of the specialty pharmaceutical company's stock valued at $148,000 after buying an additional 4,497 shares during the last quarter. The stock was sold at an average price of $18.46, for a total value of $184,600.00. The disclosure for this sale can be found here.

Abeona Therapeutics, Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. The Company's lead product candidate, Zilretta, is a late-stage, injectable, extended-release, intra-articular (IA) investigational steroid.

Share

Advertisement

Related Posts

Calciomercato Milan, Galliani frena su De Sciglio: "Mai sentita la Juventus"
"Io non ho mai parlato con la Juventus per De Sciglio ", è stata la prima risposta di Galliani . Anche per questo abbiamo scelto Montella , sta lanciando i ragazzi e c'è l'ambiente ideale".

KeyCorp Reiterates Overweight Rating for Magna International, Inc. (MGA)
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Marea Informative and is owned by of Marea Informative. United Services Automobile Association raised its position in shares of Magna International by 29.8% in the second quarter.

Sri Lanka show resolve in South Africa Test after early wicket
Acknowledging his side had been "outplayed in every department", Mathews cut a dejected figure at the post-match presentation. We kept making the same mistakes, it was very sporty here with a bit of unevenness which made it hard .

Iconic Ringling Bros. circus to close after 146 years
For the first time in the history of Ringling Brothers and Barnum and Bailey Circus, a female ringmaster is running the show. She was chosen as the next ringmaster for Circus Xtreme after a nationwide casting call.

Rep. John Lewis doesn't see Trump as a "legitimate" president
Democrats swiftly condemned Trump Saturday morning, as did many Americans, prompting Lewis' name to trend on Twitter. Trump continued with another criticism of Lewis: "All talk, talk, talk - no action or results", Trump said.

US, EU Complete Agreement On Insurance Regulation
The Treasury Department's Federal Insurance Office (FIO) and the U.S. The agreement becomes effective ninety calendar days after that date.

Milan, Galliani: "Da questa squadra soddisfazioni inattese"
Io ero bambino e andai a vedere quella partita a Chiasso perché la trasmetteva solo la televisione svizzera. Due giorni fa è venuto a trovarmi Altafini, simbolo di un Milan che vinceva già in precedenza.

Supreme Court Takes up NAM's WOTUS Case
What constitutes protected waters is hugely important to landowners, industry and environmental groups, as well as government officials.

Inter, Pioli: "Gagliardini è pronto. Contento di Gabigol"
INTER-CHIEVO PIOLI - Poi una battuta su Gabigol . "Sono un gruppo esperto e sbagliano poche partite nel corso della stagione". Io un potenziatore? Siamo soltanto a metà del percorso, non abbiamo fatto niente. "Lì tireremo le somme anche su di me".

Dallas Cowboys star running back not injured following accident
The rookie running back did his best to calm everyone down, telling the Twitterverse that he had "been in bigger collisions". As Green Bay nose tackle Letroy Guion said, "Packers are doing good right now, so let's go".

© 2015 Vivere Milano. All Rights reserved.